ATARA BIOTHERAPEUTICS, INC.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-4.8M | $-4.1M | $-4.3M | $2.4M | $38.0M | $-21.9M | $-19.0M | $-31.8M |
| Depreciation & Amortization | — | $29.0K | — | — | $1.8M | — | — | $1.4M |
| Depreciation | — | — | — | — | $300.0K | $600.0K | $700.0K | $900.0K |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | — | $749.0K | — | — | $4.2M | — | — | $8.4M |
| Net Cash from Operating Activities | $-3.3M | $-3.1M | $-9.8M | $-7.3M | $-28.1M | $-4.0M | $-10.6M | $-29.6M |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | $0 | $0 | $0 | $0 | $29.0K | $127.0K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | $0 | — | — | $17.2M | — | — | $14.7M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | — | $3.0M | — | — | $-250.0K | — | — | $24.1M |
| Net Change in Cash | — | — | — | — | — | — | — | — |
| Free Cash Flow | — | — | $-9.8M | $-7.3M | $-28.1M | $-4.0M | $-10.7M | $-29.7M |